Alum-precipitated exfoliatin was found to be an efficient antigen for eliciting high titers of neutralizing antibody in rabbits. Antitoxin thus produced, and transferred passively, was shown to protect neonatal mice against challenge with two to three lethal doses of preformed exfoliatin even when administration was delayed until 15 min before exfoliation began in control animals. Rabbit immunization. Alum-precipitated exfoliatin was prepared by adding 1 ml of 1% aluminum ammonium sulfate to 20 ml of exfoliatin solution (1.5 mg/ml) in distilled water. The mixture was neutralized with 0.1 N NaOH, 2 mg of Merthiolate was added, and the mixture was stored at 4 C. Immunization consisted of a total of 19 mg given as 0.1, 0.3, and 0.6 mg subcutaneously the first week, three intramuscular doses of 0.6 mg the second week, and twelve intravenous injections ranging from 0.3 to 2.0 mg over a month interval.
Alum-precipitated exfoliatin was found to be an efficient antigen for eliciting high titers of neutralizing antibody in rabbits. Antitoxin thus produced, and transferred passively, was shown to protect neonatal mice against challenge with two to three lethal doses of preformed exfoliatin even when administration was delayed until 15 min before exfoliation began in control animals. The same dose of antitoxin afforded some protection against six to eight lethal doses of exfoliatin provided it was given before or at the time of challenge. Antitoxin, in the doses given, did not protect against infection with an exfoliatin-producing Staphylococcus aureus strain although the onset of exfoliation was delayed.
It has recently been demonstrated that the scalded-skin syndrome in neonatal mice is caused by a protein elaborated by certain Staphylococcus aureus strains of phage group II. This protein, called exfoliatin, was partially purified and characterized (2) . Subsequently, two other groups (1, 4) (6) . The final immunoglobulin solution, concentrated four-to tenfold, was stored at -20 C until needed.
Titration of exfoliatin antitoxin. To 0.4 ml of serial twofold dilutions of serum was added 0.4 ml of a saline solution of exfoliatin containing 80 ED50. The mixtures were allowed to stand at room temperature 561 Vol. 6, No. 4 for 30 min. A 0.02-ml amount of each mixture was inoculated subcutaneously into at least three neonatal (1 day old) White Swiss mice. Control animals were inoculated with a corresponding dose (2 ED5o) of exfoliatin in 0.02 ml of saline. Three hours after inoculation, mice were examined for a positive Nikolsky sign or actual exfoliation. The highest dilution of serum which prevented the development of a positive Nikolsky sign in 50% of the mice was considered the anti-exfoliatin titer. Fifty percent end points were determined by the method of Reed and Muench (5) .
Titration of anti-alpha toxin antibody. Freshly drawn blood from normal rabbits was mixed with an equal volume of Alsever's solution and stored at 4 C until used. For use, this mixture was centrifuged, the cells were washed twice in saline, and the mixture was suspended in saline to give a 1% suspension.
To 0.4 ml of serial twofold dilutions of serum was added 0.2 ml of alpha toxin (2) in saline (containing 3 to 4 HD5o). The mixture was allowed to stand for 15 min at room temperature, and 0.4 ml of 1% rabbit erythrocyte suspension was added to each tube. The tubes were incubated for 1 hr at 37 C and centrifuged, the supernatant fluids were quantitatively removed, 4 ml of 0.1% Na2CO3 was added to each supernatant fraction, and the concentration of hemoglobin was determnined spectrophotometrically at 430 nm. The highest dilution of serum which reduced hemoglobin release by 50% was the anti-alpha toxin titer. RESULTS Exfoliatin antitoxin. Preimmunization sera revealed no anti-exfoliatin or anti-alpha toxin activity. One month after receiving exfoliatin in adjuvant, rabbits had a low but measurable antiexfoliatin titer, and this was raised to a peak titer of 1:16 with two intramuscular doses of exfoliatin in saline. However, additional injections of exfoliatin in saline failed to maintain these moderate titers (Fig. 1) Another group of 103 neonatal mice was given 12 ED50 of exfoliatin subcutaneously. Subgroups received 0.02 ml of antitoxin (titer 1:20) 2 hr before, simultaneous with, and 0.5, 1.0, 1.5, and 2 hr after exfoliatin. These subgroups consisted of 13 to 17 mice each, and 14 mice served as controls. In this case antitoxin protected about 40%,0 of challenged animals and only when administered before or concurrent with exfoliatin inoculation (Fig. 3) . Control mice demonstrated positive Nikolsky signs 1 hr after exfoliatin inoculation and were completely exfoliated 2 to 6 hr later.
Prophylaxis after infection. Twelve neonatal mice were infected subcutaneously with 107 S. aureus strain EV cells in a volume of 0.02 ml. Six mice were inoculated subcutaneously with 0.04 ml of exfoliatin antitoxin (titer 1:20); half of the dose was given 1 hr after infection and the rest 1 hr later. All 
